•
Dec 31, 2017

Emergent BioSolutions Q4 2017 Earnings Report

Total Revenue
$194M
Previous year: $152M
+27.8%
EPS
$0.74
Previous year: $0.74
+0.0%
Gross Profit
$124M
Previous year: $113M
+8.9%
Cash and Equivalents
$178M
Previous year: $272M
-34.3%
Free Cash Flow
$66.5M
Previous year: -$32.6M
-303.7%
Total Assets
$1.07B
Previous year: $970M
+10.3%

Emergent BioSolutions

Emergent BioSolutions